|
1
|
Wong IC, Ng YK and Lui VW: Cancers of the
lung, head and neck on the rise: Perspectives on the genotoxicity
of air pollution. Chin J Cancer. 33:476–480. 2014.PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Atienza JA and Dasanu CA: Incidence of
second primary malignancies in patients with treated head and neck
cancer: A comprehensive review of literature. Curr Med Res Opin.
28:1899–1909. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mork J, Lie AK, Glattre E, Hallmans G,
Jellum E, Koskela P, Møller B, Pukkala E, Schiller JT, Youngman L,
et al: Human papillomavirus infection as a risk factor for
squamous-cell carcinoma of the head and neck. N Engl J Med.
344:1125–1131. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ang KK, Harris J, Wheeler R, Weber R,
Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C,
et al: Human papillomavirus and survival of patients with
oropharyngeal cancer. N Engl J Med. 363:24–35. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chaturvedi AK, Engels EA, Pfeiffer RM,
Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M,
Cozen W, et al: Human papillomavirus and rising oropharyngeal
cancer incidence in the united states. J Clin Oncol. 29:4294–4301.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ndiaye C, Mena M, Alemany L, Arbyn M,
Castellsagué X, Laporte L, Bosch FX, de Sanjosé S and Trottier H:
HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck
cancers: A systematic review and meta-analysis. Lancet Oncol.
15:1319–1331. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bouda M, Gorgoulis VG, Kastrinakis NG,
Giannoudis A, Tsoli E, Danassi-Afentaki D, Foukas P, Kyroudi A,
Laskaris G, Herrington CS and Kittas C: ‘High risk’ HPV types are
frequently detected in potentially malignant and malignant oral
lesions, but not in normal oral mucosa. Mod Pathol. 13:644–653.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Paradiso A, Ranieri G, Stea B, Zito A,
Zehbe I, Tommasino M, Grammatica L and De Lena M: Altered p16INK4a
and Fhit expression in carcinogenesis and progression of human oral
cancer. Int J Oncol. 24:249–255. 2004.PubMed/NCBI
|
|
11
|
Bradley KT, Budnick SD and Logani S:
Immunohistochemical detection of p16INK4a in dysplastic lesions of
the oral cavity. Mod Pathol. 19:1310–1316. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Baumann JL, Cohen S, Evjen AN, Law JH,
Vadivelu S, Attia A, Schindler JS, Chung CH, Wirth PS, Meijer CJ,
et al: Human papillomavirus in early laryngeal carcinoma.
Laryngoscope. 119:1531–1537. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Halec G, Holzinger D, Schmitt M,
Flechtenmacher C, Dyckhoff G, Lloveras B, Höfler D, Bosch FX and
Pawlita M: Biological evidence for a causal role of HPV16 in a
small fraction of laryngeal squamous cell carcinoma. Br J Cancer.
109:172–183. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu Y, Liu S, Yi H, Wang J, Dong P, Li X
and Yin S: Human papillomavirus infection in 674 Chinese patients
with laryngeal squamous cell carcinoma. PLoS One. 9:e1159142014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Young RJ, Urban D, Angel C, Corry J, Lyons
B, Vallance N, Kleid S, Iseli TA, Solomon B and Rischin D:
Frequency and prognostic significance of p16(INK4A) protein
overexpression and transcriptionally active human papillomavirus
infection in laryngeal squamous cell carcinoma. Br J Cancer.
112:1098–1104. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shi W, Kato H, Perez-Ordonez B, Pintilie
M, Huang S, Hui A, O'Sullivan B, Waldron J, Cummings B, Kim J, et
al: Comparative prognostic value of HPV16 E6 mRNA compared with in
situ hybridization for human oropharyngeal squamous carcinoma. J
Clin Oncol. 27:6213–6221. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rischin D, Young RJ, Fisher R, Fox SB, Le
QT, Peters LJ, Solomon B, Choi J, O'Sullivan B, Kenny LM and
McArthur GA: Prognostic significance of p16INK4A and human
papillomavirus in patients with oropharyngeal cancer treated on
TROG 02.02 phase III trial. J Clin Oncol. 28:4142–4148. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jordan RC, Lingen MW, Perez-Ordonez B, He
X, Pickard R, Koluder M, Jiang B, Wakely P, Xiao W and Gillison ML:
Validation of methods for oropharyngeal cancer HPV status
determination in US cooperative group trials. Am J Surg Pathol.
36:945–954. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Buajeeb W, Poomsawat S, Punyasingh J and
Sanguansin S: Expression of p16 in oral cancer and premalignant
lesions. J Oral Pathol Med. 38:104–108. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bussu F, Sali M, Gallus R, Vellone VG,
Zannoni GF, Autorino R, Dinapoli N, Santangelo R, Martucci R,
Graziani C, et al: HPV infection in squamous cell carcinomas
arising from different mucosal sites of the head and neck region.
Is p16 immunohistochemistry a reliable surrogate marker? Br J
Cancer. 108:1157–1162. 2013.PubMed/NCBI
|
|
21
|
Chung CH, Zhang Q, Kong CS, Harris J,
Fertig EJ, Harari PM, Wang D, Redmond KP, Shenouda G, Trotti A, et
al: p16 protein expression and human papillomavirus status as
prognostic biomarkers of nonoropharyngeal head and neck squamous
cell carcinoma. J Clin Oncol. 32:3930–3938. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lim AM, Do H, Young RJ, Wong SQ, Angel C,
Collins M, Takano EA, Corry J, Wiesenfeld D, Kleid S, et al:
Differential mechanisms of CDKN2A (p16) alteration in oral tongue
squamous cell carcinomas and correlation with patient outcome. Int
J Cancer. 135:887–895. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu Y, Liu S, Yi H, Wang J, Luo Y and Yin
S: Low prevalence of human papillomavirus in head and neck squamous
cell carcinoma in chinese patients. J Med Virol. 87:281–286. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fu ZJ, Ma ZY, Wang QR, Lei DP, Wang R, Liu
CX and Pan XL: Overexpression of cyclind1 and underexpression of
p16 correlate with lymph node metastases in laryngeal squamous cell
carcinoma in chinese patients. Clin Exp Metastasis. 25:887–892.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li D, Zhang Q and Zhang X: Expression and
clinical significance of MDM2 and P16 in laryngeal squamous cell
carcinoma. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi.
26:802–805. 2012.(In Chinese). PubMed/NCBI
|
|
26
|
Edge SB and Compton CC: The american joint
committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schache AG, Liloglou T, Risk JM, Filia A,
Jones TM, Sheard J, Woolgar JA, Helliwell TR, Triantafyllou A,
Robinson M, et al: Evaluation of human papilloma virus diagnostic
testing in oropharyngeal squamous cell carcinoma: Sensitivity,
specificity, and prognostic discrimination. Clin Cancer Res.
17:6262–6271. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schlecht NF, Brandwein-Gensler M, Nuovo
GJ, Li M, Dunne A, Kawachi N, Smith RV, Burk RD and Prystowsky MB:
A comparison of clinically utilized human papillomavirus detection
methods in head and neck cancer. Mod Pathol. 24:1295–1305. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Doxtader EE and Katzenstein AL: The
relationship between p16 expression and high-risk human
papillomavirus infection in squamous cell carcinomas from sites
other than uterine cervix: A study of 137 cases. Hum Pathol.
43:327–332. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
van Monsjou HS, van Velthuysen ML, van den
Brekel MW, Jordanova ES, Melief CJ and Balm AJ: Human
papillomavirus status in young patients with head and neck squamous
cell carcinoma. Int J Cancer. 130:1806–1812. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Posner MR, Lorch JH, Goloubeva O, Tan M,
Schumaker LM, Sarlis NJ, Haddad RI and Cullen KJ: Survival and
human papillomavirus in oropharynx cancer in TAX 324: A subset
analysis from an international phase III trial. Ann Oncol.
22:1071–1077. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rietbergen MM, Brakenhoff RH, Bloemena E,
Witte BI, Snijders PJ, Heideman DA, Boon D, Koljenovic S,
Baatenburg-de Jong RJ and Leemans CR: Human papillomavirus
detection and comorbidity: Critical issues in selection of patients
with oropharyngeal cancer for treatment De-escalation trials. Ann
Oncol. 24:2740–2745. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kalfert D, Celakovsky P, Laco J and
Ludvikova M: The role of protein p16(INK4a) in glottic laryngeal
squamous cell carcinoma. Pathol Oncol Res. 20:909–915. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Forastiere AA, Goepfert H, Maor M, Pajak
TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, et
al: Concurrent chemotherapy and radiotherapy for organ preservation
in advanced laryngeal cancer. N Engl J Med. 349:2091–2098. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Adelstein DJ, Saxton JP, Rybicki LA,
Esclamado RM, Wood BG, Strome M, Lavertu P, Lorenz RR and Carroll
MA: Multiagent concurrent chemoradiotherapy for locoregionally
advanced squamous cell head and neck cancer: Mature results from a
single institution. J Clin Oncol. 24:1064–1071. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Machtay M, Moughan J, Trotti A, Garden AS,
Weber RS, Cooper JS, Forastiere A and Ang KK: Factors associated
with severe late toxicity after concurrent chemoradiation for
locally advanced head and neck cancer: An RTOG analysis. J Clin
Oncol. 26:3582–3589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Corry J, Peters LJ and Rischin D:
Optimising the therapeutic ratio in head and neck cancer. Lancet
Oncol. 11:287–291. 2010. View Article : Google Scholar : PubMed/NCBI
|
